Exploring regulatory flexibility to create novel incentives to optimize drug discovery
Efforts by governments, firms, and patients to deliver pioneering drugs for critical health needs face a challenge of diminishing efficiency in developing those medicines. While multi-sectoral collaborations involving firms, researchers, patients, and policymakers are widely recognized as crucial fo...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2024-05-01
|
| Reeks: | Frontiers in Medicine |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1379966/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|